JASMINE FRANKLIN: Open Payments
NPI 1659925667 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 14 payments from 10 companies in 2025. Trend: 2023 $174 · 2024 $56 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $66 |
| On Target Laboratories, Inc | 3 | $58 |
| Medtronic, Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Octapharma USA, Inc. | 1 | $31 |
| Acera Surgical, Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| EnableCV Inc. | 1 | $22 |
| Bard Peripheral Vascular, Inc. | 1 | $19 |
| Ossur Americas, Inc. | 1 | $18 |
Products named: Cytalux, AVALUS, Varithena Administration Pack, LIVTENCITY, FIBRYGA, Restrata Wound Matrix, INSPIRE, THRUPORT SYSTEMS INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE.
Industry payments across TX — which companies pay providers there.
